Prevalence, Clinical Characteristics, and Prognostic Impact of Kidney Disease on Heart Failure Patients: An Observational Study of the Colombian Heart Failure Registry

Abstract Introduction: Chronic kidney disease (CKD) represents one of the most frequent comorbidities observed in heart failure (HF) patients and has been observed to increase this population’s risk of adverse outcomes. Nevertheless, evidence analyzing kidney dysfunction in HF is scarce in Latin Ame...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiorenal medicine 2023-01, Vol.13 (1), p.292-300
Hauptverfasser: López-Ponce de León, Juan David, Gómez-Mesa, Juan Esteban, Saldarriaga, Clara, Echeverría, Luis Eduardo, Posada-Bastidas, Alejandro, García, Juan Camilo, Ochoa-Morón, Alejandro David, Rolong, Balkis, Manzur-Jatin, Fernando, Mosquera-Jiménez, José Ignacio, Pacheco-Jiménez, Oscar Alfredo, Rodríguez-Cerón, Álvaro Hernán, Rodríguez-Gómez, Patricia, Rivera-Toquica, Fernando, Rivera-Toquica, Alex
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 300
container_issue 1
container_start_page 292
container_title Cardiorenal medicine
container_volume 13
creator López-Ponce de León, Juan David
Gómez-Mesa, Juan Esteban
Saldarriaga, Clara
Echeverría, Luis Eduardo
Posada-Bastidas, Alejandro
García, Juan Camilo
Ochoa-Morón, Alejandro David
Rolong, Balkis
Manzur-Jatin, Fernando
Mosquera-Jiménez, José Ignacio
Pacheco-Jiménez, Oscar Alfredo
Rodríguez-Cerón, Álvaro Hernán
Rodríguez-Gómez, Patricia
Rivera-Toquica, Fernando
Rivera-Toquica, Alex
description Abstract Introduction: Chronic kidney disease (CKD) represents one of the most frequent comorbidities observed in heart failure (HF) patients and has been observed to increase this population’s risk of adverse outcomes. Nevertheless, evidence analyzing kidney dysfunction in HF is scarce in Latin American populations. We aimed to analyze the prevalence of kidney dysfunction and assess its association with mortality in patients diagnosed with HF enrolled in the Colombian Heart Failure Registry (RECOLFACA). Methods: RECOLFACA enrolled adult patients with HF diagnosis from 60 centers in Colombia during the period 2017–2019. The primary outcome was all-cause mortality. A Cox proportional-hazards regression model was used to assess the impact of the different categories of eGFR in mortality risk. A p value of
doi_str_mv 10.1159/000530852
format Article
fullrecord <record><control><sourceid>proquest_karge</sourceid><recordid>TN_cdi_karger_primary_530852</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2820029828</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-bc17c163bd28c71ce1895c3400a265ca8c80cb02a77b280337decebf1da63ea13</originalsourceid><addsrcrecordid>eNptkU1P5DAMhiO0CBBw4I5QpL2AxEA-pm26N1Q-BYgRH-fKTd0h0CazSYo0v2j_5nY0wxxWe7JlP35t-SXkgLMzzpP8nDGWSKYSsUF2eJqOR0nCxI9VLpVQ22Q_hA-24FKes2SLbMtMSK7UeIf8mXj8ghatxlNatMYaDS0t3sGDjuhNiEaHUwq2phPvptYtCvSumw1t6hp6b2qLc3ppAkJA6iy9RfCRXoNpe490AtGgjeEXvbD0qQrov4aKs8OSl9jX84VGfEdauNZ1lYF_559xOtzg53tks4E24P4q7pK366vX4nb08HRzV1w8jLRM8ziqNM80T2VVC6UzrpGrPNFyzBiINNGgtGK6YgKyrBKKSZnVqLFqeA2pROBylxwvdWfe_e4xxLIzQWPbgkXXh1IowZjIh7cO6MkS1d6F4LEpZ9504OclZ-XCmnJtzcAerWT7qsN6TX4bMQCHS-AT_BT9GljP__xvu3h-XBLlrG7kX2GSn58</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2820029828</pqid></control><display><type>article</type><title>Prevalence, Clinical Characteristics, and Prognostic Impact of Kidney Disease on Heart Failure Patients: An Observational Study of the Colombian Heart Failure Registry</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Karger Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>López-Ponce de León, Juan David ; Gómez-Mesa, Juan Esteban ; Saldarriaga, Clara ; Echeverría, Luis Eduardo ; Posada-Bastidas, Alejandro ; García, Juan Camilo ; Ochoa-Morón, Alejandro David ; Rolong, Balkis ; Manzur-Jatin, Fernando ; Mosquera-Jiménez, José Ignacio ; Pacheco-Jiménez, Oscar Alfredo ; Rodríguez-Cerón, Álvaro Hernán ; Rodríguez-Gómez, Patricia ; Rivera-Toquica, Fernando ; Rivera-Toquica, Alex</creator><creatorcontrib>López-Ponce de León, Juan David ; Gómez-Mesa, Juan Esteban ; Saldarriaga, Clara ; Echeverría, Luis Eduardo ; Posada-Bastidas, Alejandro ; García, Juan Camilo ; Ochoa-Morón, Alejandro David ; Rolong, Balkis ; Manzur-Jatin, Fernando ; Mosquera-Jiménez, José Ignacio ; Pacheco-Jiménez, Oscar Alfredo ; Rodríguez-Cerón, Álvaro Hernán ; Rodríguez-Gómez, Patricia ; Rivera-Toquica, Fernando ; Rivera-Toquica, Alex</creatorcontrib><description>Abstract Introduction: Chronic kidney disease (CKD) represents one of the most frequent comorbidities observed in heart failure (HF) patients and has been observed to increase this population’s risk of adverse outcomes. Nevertheless, evidence analyzing kidney dysfunction in HF is scarce in Latin American populations. We aimed to analyze the prevalence of kidney dysfunction and assess its association with mortality in patients diagnosed with HF enrolled in the Colombian Heart Failure Registry (RECOLFACA). Methods: RECOLFACA enrolled adult patients with HF diagnosis from 60 centers in Colombia during the period 2017–2019. The primary outcome was all-cause mortality. A Cox proportional-hazards regression model was used to assess the impact of the different categories of eGFR in mortality risk. A p value of &lt;0.05 was considered significant. All statistical tests were two-tailed. Results: From the total 2,514 evaluated patients, 1,501 (59.7%) patients had moderate kidney dysfunction (eGFR &lt;60 mL/min/1.73 m2), while 221 (8.8%) patients were classified as having a severe kidney dysfunction (eGFR &lt;30 mL/min/1.73 m2). Patients with lower kidney function were most commonly males, had higher median age, and reported a higher prevalence of cardiovascular comorbidities. Moreover, different patterns of medications prescription were observed when comparing CKD versus non-CKD patients. Finally, eGFR &lt;30 mL/min/1.73 m2 was significantly associated with a higher mortality risk compared to eGFR &gt;90 mL/min/1.73 m2 status (HR: 1.87; 95% CI, 1.10–3.18), even after an extensive adjustment by relevant covariates. Conclusion: CKD represents a prevalent condition in the setting of HF. Patients with CKD and HF present with multiple sociodemographic, clinical, and laboratory differences compared with those only diagnosed with HF and present a significantly higher risk of mortality. A timely diagnosis and optimal treatment and follow-up of CKD in the setting of HF may improve the prognosis of these patients and prevent adverse outcomes.</description><identifier>ISSN: 1664-3828</identifier><identifier>EISSN: 1664-5502</identifier><identifier>DOI: 10.1159/000530852</identifier><identifier>PMID: 37231884</identifier><language>eng</language><publisher>Basel, Switzerland</publisher><subject>Adult ; Colombia - epidemiology ; Heart Failure - complications ; Heart Failure - diagnosis ; Heart Failure - epidemiology ; Humans ; Male ; Prevalence ; Prognosis ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - epidemiology ; Research Article</subject><ispartof>Cardiorenal medicine, 2023-01, Vol.13 (1), p.292-300</ispartof><rights>2023 The Author(s). Published by S. Karger AG, Basel</rights><rights>2023 The Author(s). Published by S. Karger AG, Basel.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-bc17c163bd28c71ce1895c3400a265ca8c80cb02a77b280337decebf1da63ea13</citedby><cites>FETCH-LOGICAL-c369t-bc17c163bd28c71ce1895c3400a265ca8c80cb02a77b280337decebf1da63ea13</cites><orcidid>0000-0002-6066-1367 ; 0000-0003-3453-9605</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27633,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37231884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>López-Ponce de León, Juan David</creatorcontrib><creatorcontrib>Gómez-Mesa, Juan Esteban</creatorcontrib><creatorcontrib>Saldarriaga, Clara</creatorcontrib><creatorcontrib>Echeverría, Luis Eduardo</creatorcontrib><creatorcontrib>Posada-Bastidas, Alejandro</creatorcontrib><creatorcontrib>García, Juan Camilo</creatorcontrib><creatorcontrib>Ochoa-Morón, Alejandro David</creatorcontrib><creatorcontrib>Rolong, Balkis</creatorcontrib><creatorcontrib>Manzur-Jatin, Fernando</creatorcontrib><creatorcontrib>Mosquera-Jiménez, José Ignacio</creatorcontrib><creatorcontrib>Pacheco-Jiménez, Oscar Alfredo</creatorcontrib><creatorcontrib>Rodríguez-Cerón, Álvaro Hernán</creatorcontrib><creatorcontrib>Rodríguez-Gómez, Patricia</creatorcontrib><creatorcontrib>Rivera-Toquica, Fernando</creatorcontrib><creatorcontrib>Rivera-Toquica, Alex</creatorcontrib><title>Prevalence, Clinical Characteristics, and Prognostic Impact of Kidney Disease on Heart Failure Patients: An Observational Study of the Colombian Heart Failure Registry</title><title>Cardiorenal medicine</title><addtitle>Cardiorenal Med</addtitle><description>Abstract Introduction: Chronic kidney disease (CKD) represents one of the most frequent comorbidities observed in heart failure (HF) patients and has been observed to increase this population’s risk of adverse outcomes. Nevertheless, evidence analyzing kidney dysfunction in HF is scarce in Latin American populations. We aimed to analyze the prevalence of kidney dysfunction and assess its association with mortality in patients diagnosed with HF enrolled in the Colombian Heart Failure Registry (RECOLFACA). Methods: RECOLFACA enrolled adult patients with HF diagnosis from 60 centers in Colombia during the period 2017–2019. The primary outcome was all-cause mortality. A Cox proportional-hazards regression model was used to assess the impact of the different categories of eGFR in mortality risk. A p value of &lt;0.05 was considered significant. All statistical tests were two-tailed. Results: From the total 2,514 evaluated patients, 1,501 (59.7%) patients had moderate kidney dysfunction (eGFR &lt;60 mL/min/1.73 m2), while 221 (8.8%) patients were classified as having a severe kidney dysfunction (eGFR &lt;30 mL/min/1.73 m2). Patients with lower kidney function were most commonly males, had higher median age, and reported a higher prevalence of cardiovascular comorbidities. Moreover, different patterns of medications prescription were observed when comparing CKD versus non-CKD patients. Finally, eGFR &lt;30 mL/min/1.73 m2 was significantly associated with a higher mortality risk compared to eGFR &gt;90 mL/min/1.73 m2 status (HR: 1.87; 95% CI, 1.10–3.18), even after an extensive adjustment by relevant covariates. Conclusion: CKD represents a prevalent condition in the setting of HF. Patients with CKD and HF present with multiple sociodemographic, clinical, and laboratory differences compared with those only diagnosed with HF and present a significantly higher risk of mortality. A timely diagnosis and optimal treatment and follow-up of CKD in the setting of HF may improve the prognosis of these patients and prevent adverse outcomes.</description><subject>Adult</subject><subject>Colombia - epidemiology</subject><subject>Heart Failure - complications</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - epidemiology</subject><subject>Humans</subject><subject>Male</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - epidemiology</subject><subject>Research Article</subject><issn>1664-3828</issn><issn>1664-5502</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>EIF</sourceid><recordid>eNptkU1P5DAMhiO0CBBw4I5QpL2AxEA-pm26N1Q-BYgRH-fKTd0h0CazSYo0v2j_5nY0wxxWe7JlP35t-SXkgLMzzpP8nDGWSKYSsUF2eJqOR0nCxI9VLpVQ22Q_hA-24FKes2SLbMtMSK7UeIf8mXj8ghatxlNatMYaDS0t3sGDjuhNiEaHUwq2phPvptYtCvSumw1t6hp6b2qLc3ppAkJA6iy9RfCRXoNpe490AtGgjeEXvbD0qQrov4aKs8OSl9jX84VGfEdauNZ1lYF_559xOtzg53tks4E24P4q7pK366vX4nb08HRzV1w8jLRM8ziqNM80T2VVC6UzrpGrPNFyzBiINNGgtGK6YgKyrBKKSZnVqLFqeA2pROBylxwvdWfe_e4xxLIzQWPbgkXXh1IowZjIh7cO6MkS1d6F4LEpZ9504OclZ-XCmnJtzcAerWT7qsN6TX4bMQCHS-AT_BT9GljP__xvu3h-XBLlrG7kX2GSn58</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>López-Ponce de León, Juan David</creator><creator>Gómez-Mesa, Juan Esteban</creator><creator>Saldarriaga, Clara</creator><creator>Echeverría, Luis Eduardo</creator><creator>Posada-Bastidas, Alejandro</creator><creator>García, Juan Camilo</creator><creator>Ochoa-Morón, Alejandro David</creator><creator>Rolong, Balkis</creator><creator>Manzur-Jatin, Fernando</creator><creator>Mosquera-Jiménez, José Ignacio</creator><creator>Pacheco-Jiménez, Oscar Alfredo</creator><creator>Rodríguez-Cerón, Álvaro Hernán</creator><creator>Rodríguez-Gómez, Patricia</creator><creator>Rivera-Toquica, Fernando</creator><creator>Rivera-Toquica, Alex</creator><scope>M--</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6066-1367</orcidid><orcidid>https://orcid.org/0000-0003-3453-9605</orcidid></search><sort><creationdate>20230101</creationdate><title>Prevalence, Clinical Characteristics, and Prognostic Impact of Kidney Disease on Heart Failure Patients: An Observational Study of the Colombian Heart Failure Registry</title><author>López-Ponce de León, Juan David ; Gómez-Mesa, Juan Esteban ; Saldarriaga, Clara ; Echeverría, Luis Eduardo ; Posada-Bastidas, Alejandro ; García, Juan Camilo ; Ochoa-Morón, Alejandro David ; Rolong, Balkis ; Manzur-Jatin, Fernando ; Mosquera-Jiménez, José Ignacio ; Pacheco-Jiménez, Oscar Alfredo ; Rodríguez-Cerón, Álvaro Hernán ; Rodríguez-Gómez, Patricia ; Rivera-Toquica, Fernando ; Rivera-Toquica, Alex</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-bc17c163bd28c71ce1895c3400a265ca8c80cb02a77b280337decebf1da63ea13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adult</topic><topic>Colombia - epidemiology</topic><topic>Heart Failure - complications</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - epidemiology</topic><topic>Humans</topic><topic>Male</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - epidemiology</topic><topic>Research Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>López-Ponce de León, Juan David</creatorcontrib><creatorcontrib>Gómez-Mesa, Juan Esteban</creatorcontrib><creatorcontrib>Saldarriaga, Clara</creatorcontrib><creatorcontrib>Echeverría, Luis Eduardo</creatorcontrib><creatorcontrib>Posada-Bastidas, Alejandro</creatorcontrib><creatorcontrib>García, Juan Camilo</creatorcontrib><creatorcontrib>Ochoa-Morón, Alejandro David</creatorcontrib><creatorcontrib>Rolong, Balkis</creatorcontrib><creatorcontrib>Manzur-Jatin, Fernando</creatorcontrib><creatorcontrib>Mosquera-Jiménez, José Ignacio</creatorcontrib><creatorcontrib>Pacheco-Jiménez, Oscar Alfredo</creatorcontrib><creatorcontrib>Rodríguez-Cerón, Álvaro Hernán</creatorcontrib><creatorcontrib>Rodríguez-Gómez, Patricia</creatorcontrib><creatorcontrib>Rivera-Toquica, Fernando</creatorcontrib><creatorcontrib>Rivera-Toquica, Alex</creatorcontrib><collection>Karger Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiorenal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>López-Ponce de León, Juan David</au><au>Gómez-Mesa, Juan Esteban</au><au>Saldarriaga, Clara</au><au>Echeverría, Luis Eduardo</au><au>Posada-Bastidas, Alejandro</au><au>García, Juan Camilo</au><au>Ochoa-Morón, Alejandro David</au><au>Rolong, Balkis</au><au>Manzur-Jatin, Fernando</au><au>Mosquera-Jiménez, José Ignacio</au><au>Pacheco-Jiménez, Oscar Alfredo</au><au>Rodríguez-Cerón, Álvaro Hernán</au><au>Rodríguez-Gómez, Patricia</au><au>Rivera-Toquica, Fernando</au><au>Rivera-Toquica, Alex</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence, Clinical Characteristics, and Prognostic Impact of Kidney Disease on Heart Failure Patients: An Observational Study of the Colombian Heart Failure Registry</atitle><jtitle>Cardiorenal medicine</jtitle><addtitle>Cardiorenal Med</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>13</volume><issue>1</issue><spage>292</spage><epage>300</epage><pages>292-300</pages><issn>1664-3828</issn><eissn>1664-5502</eissn><abstract>Abstract Introduction: Chronic kidney disease (CKD) represents one of the most frequent comorbidities observed in heart failure (HF) patients and has been observed to increase this population’s risk of adverse outcomes. Nevertheless, evidence analyzing kidney dysfunction in HF is scarce in Latin American populations. We aimed to analyze the prevalence of kidney dysfunction and assess its association with mortality in patients diagnosed with HF enrolled in the Colombian Heart Failure Registry (RECOLFACA). Methods: RECOLFACA enrolled adult patients with HF diagnosis from 60 centers in Colombia during the period 2017–2019. The primary outcome was all-cause mortality. A Cox proportional-hazards regression model was used to assess the impact of the different categories of eGFR in mortality risk. A p value of &lt;0.05 was considered significant. All statistical tests were two-tailed. Results: From the total 2,514 evaluated patients, 1,501 (59.7%) patients had moderate kidney dysfunction (eGFR &lt;60 mL/min/1.73 m2), while 221 (8.8%) patients were classified as having a severe kidney dysfunction (eGFR &lt;30 mL/min/1.73 m2). Patients with lower kidney function were most commonly males, had higher median age, and reported a higher prevalence of cardiovascular comorbidities. Moreover, different patterns of medications prescription were observed when comparing CKD versus non-CKD patients. Finally, eGFR &lt;30 mL/min/1.73 m2 was significantly associated with a higher mortality risk compared to eGFR &gt;90 mL/min/1.73 m2 status (HR: 1.87; 95% CI, 1.10–3.18), even after an extensive adjustment by relevant covariates. Conclusion: CKD represents a prevalent condition in the setting of HF. Patients with CKD and HF present with multiple sociodemographic, clinical, and laboratory differences compared with those only diagnosed with HF and present a significantly higher risk of mortality. A timely diagnosis and optimal treatment and follow-up of CKD in the setting of HF may improve the prognosis of these patients and prevent adverse outcomes.</abstract><cop>Basel, Switzerland</cop><pmid>37231884</pmid><doi>10.1159/000530852</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-6066-1367</orcidid><orcidid>https://orcid.org/0000-0003-3453-9605</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3828
ispartof Cardiorenal medicine, 2023-01, Vol.13 (1), p.292-300
issn 1664-3828
1664-5502
language eng
recordid cdi_karger_primary_530852
source MEDLINE; DOAJ Directory of Open Access Journals; Karger Open Access; EZB-FREE-00999 freely available EZB journals
subjects Adult
Colombia - epidemiology
Heart Failure - complications
Heart Failure - diagnosis
Heart Failure - epidemiology
Humans
Male
Prevalence
Prognosis
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - epidemiology
Research Article
title Prevalence, Clinical Characteristics, and Prognostic Impact of Kidney Disease on Heart Failure Patients: An Observational Study of the Colombian Heart Failure Registry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T13%3A19%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence,%20Clinical%20Characteristics,%20and%20Prognostic%20Impact%20of%20Kidney%20Disease%20on%20Heart%20Failure%20Patients:%20An%20Observational%20Study%20of%20the%20Colombian%20Heart%20Failure%20Registry&rft.jtitle=Cardiorenal%20medicine&rft.au=L%C3%B3pez-Ponce%20de%20Le%C3%B3n,%20Juan%20David&rft.date=2023-01-01&rft.volume=13&rft.issue=1&rft.spage=292&rft.epage=300&rft.pages=292-300&rft.issn=1664-3828&rft.eissn=1664-5502&rft_id=info:doi/10.1159/000530852&rft_dat=%3Cproquest_karge%3E2820029828%3C/proquest_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2820029828&rft_id=info:pmid/37231884&rfr_iscdi=true